Award
Definitive Contract #75F40122C00191
HHS Awards $2.66M Contract to Northwestern University for Drug Name Safety Research
Buyer
Food and Drug Administration
Award Amount
$1,184,887.97
Ceiling
$2,656,574.97
Period of Performance
Sep 21, 2022 – Sep 29, 2027
Identifier
75F40122C00191
NAICS
541714
This definitive contract awarded by the Department of Health and Human Services (HHS) to Northwestern University focuses on assessing the effectiveness of text enhancements to prevent drug name confusion errors. The awarded contract has a potential total value of $2,656,574.97, with the current total valued at $1,184,887.97. Northwestern University, categorized as an other than small business, will undertake this significant project essential for improving medication safety and public health. The scope of work includes various deliverables and services aimed at enhancing drug name clarity and reducing medication errors. The contract was awarded through full and open competition with no set-aside designation. Key subcontractors include the University of Illinois and the Institute for Safe Medication Practices, contributing to the research efforts. The contract period spans from September 21, 2022, to September 30, 2026, with critical milestones assessed throughout this timeframe.
Description
EO 14398 - ASSESSING THE EFFECTIVENESS OF TEXT ENHANCEMENTS TO PREVENT DRUG NAME CONFUSION ERRORS. NCE